Cargando…
Update of Potential Biomarkers in Risk Prediction and Monitoring of Atherosclerosis in Systemic Lupus Erythematosus to Prevent Cardiovascular Disease
Systemic lupus erythematosus is a chronic connective tissue disease associated with an increased risk of premature atherosclerosis. It is estimated that approximately 10% of SLE patients develop significant atherosclerosis each year, which is responsible for premature cardiovascular disease that is...
Autores principales: | Blachut, Dominika, Przywara-Chowaniec, Brygida, Tomasik, Andrzej, Kukulski, Tomasz, Morawiec, Beata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604001/ https://www.ncbi.nlm.nih.gov/pubmed/37893187 http://dx.doi.org/10.3390/biomedicines11102814 |
Ejemplares similares
-
The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
por: Blachut, Dominika, et al.
Publicado: (2022) -
Systemic Lupus Erythematosus, Its Impact on Selected Cardiovascular Risk Factors, and Correlation with Duration of Illness: A Pilot Study
por: Przywara-Chowaniec, Brygida, et al.
Publicado: (2020) -
Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
por: Nowak, Agnieszka, et al.
Publicado: (2021) -
Systemic lupus erythematosus and glycation process
por: NOWAK, AGNIESZKA, et al.
Publicado: (2020) -
Evaluation of the intima-media complex in patients with systemic lupus erythematosus
por: Przywara-Chowaniec, Brygida, et al.
Publicado: (2014)